BIOCRYST PHARM (BO1 MU) stock market data APIs
€6.5029
-0.01(-0.2%)
as of December 30, 2025
Try our APIs with
free plan!
BIOCRYST PHARM Financial Data Overview
Price chart is built with
Anychart
There is no Profile data available for BO1.MU.
Prev. Close
6.5029
Open
6.4927
High
6.5067
Low
6.4856
52 wk Range
5.428-9.89
Market Cap
1 856 M
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get BIOCRYST PHARM data using free add-ons & libraries
Get BIOCRYST PHARM Fundamental Data
BIOCRYST PHARM Fundamental data includes:
- Net Revenue:
- EBITDA:
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: NaN
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
BIOCRYST PHARM News
New
BioCryst Pharmaceuticals Face Numerous Important Catalysts in 2026, Wedbush Says
BioCryst Pharmaceuticals (BCRX) faces multiple near-term catalysts and a strong commercial business PREMIUM Upgrade to read this MT Newswires article and get so much more. A Silver or Gold subscrip...
H.C. Wainwright Lifts PT on BioCryst Pharmaceuticals (BCRX) to $32 From $30
BioCryst Pharmaceuticals Inc. (NASDAQ:BCRX) is one of the best small cap stocks to buy with huge upside potential. H.C. Wainwright lifted the price target on BioCryst Pharmaceuticals Inc. (NASDAQ:BCRX...
Does The Market Misread BioCryst Pharmaceuticals After DCF Upside And Low Sales Multiple In 2025?
Wondering if BioCryst Pharmaceuticals at around $7.59 is quietly setting up a value opportunity, or just another volatile biotech swing? Let us unpack what the market is really pricing in here. The st...
Wedbush Predicts Up to ~600% Jump for These 2 ‘Strong Buy’ Stocks
After a blistering run, the stock market has lately found itself stuck in a bit of a trading rut, with more and more chatter that the AI boom is drifting from ‘transformational’ toward ‘show-me-...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
